Trinity Biotech PLC (TRIB)
1.82
-0.06
(-3.19%)
USD |
NASDAQ |
Apr 19, 12:25
Trinity Biotech Total Assets (Quarterly): 63.60M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 63.60M |
| June 30, 2023 | 71.99M |
| March 31, 2023 | 91.16M |
| December 31, 2022 | 92.10M |
| September 30, 2022 | 97.90M |
| June 30, 2022 | 107.14M |
| March 31, 2022 | 106.10M |
| December 31, 2021 | 118.90M |
| September 30, 2021 | 122.78M |
| June 30, 2021 | 124.72M |
| March 31, 2021 | 135.98M |
| December 31, 2020 | 130.40M |
| September 30, 2020 | 136.08M |
| June 30, 2020 | 128.73M |
| March 31, 2020 | 129.13M |
| December 31, 2019 | 131.07M |
| September 30, 2019 | 173.25M |
| June 30, 2019 | 171.70M |
| March 31, 2019 | 172.65M |
| December 31, 2018 | 151.66M |
| September 30, 2018 | 183.33M |
| June 30, 2018 | 194.45M |
| March 31, 2018 | 194.68M |
| December 31, 2017 | 192.97M |
| September 30, 2017 | 244.62M |
| Date | Value |
|---|---|
| June 30, 2017 | 244.80M |
| March 31, 2017 | 245.14M |
| December 31, 2016 | 249.59M |
| September 30, 2016 | 360.47M |
| June 30, 2016 | 357.77M |
| March 31, 2016 | 360.04M |
| December 31, 2015 | 363.68M |
| September 30, 2015 | 355.38M |
| June 30, 2015 | 359.76M |
| March 31, 2015 | 246.78M |
| December 31, 2014 | 242.84M |
| September 30, 2014 | 237.00M |
| June 30, 2014 | 238.45M |
| March 31, 2014 | 228.92M |
| December 31, 2013 | 226.49M |
| September 30, 2013 | 222.88M |
| June 30, 2013 | 203.44M |
| March 31, 2013 | 203.38M |
| December 31, 2012 | 197.41M |
| September 30, 2012 | 189.91M |
| June 30, 2012 | 183.95M |
| March 31, 2012 | 181.96M |
| December 31, 2011 | 171.50M |
| September 30, 2011 | 169.51M |
| June 30, 2011 | 168.03M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
63.60M
Minimum
Sep 2023
173.25M
Maximum
Sep 2019
118.48M
Average
123.75M
Median
Total Assets (Quarterly) Benchmarks
| Amarin Corp PLC | 831.68M |
| Avadel Pharmaceuticals PLC | 164.70M |
| DBV Technologies SA | 182.99M |
| Adaptimmune Therapeutics PLC | 282.62M |
| Akari Therapeutics PLC | 4.355M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 81.08M |
| Shareholders Equity (Quarterly) | -17.49M |
| Debt to Equity Ratio | -3.116 |
| Current Ratio | 3.441 |
| Net Debt Paydown Yield | 0.44% |